Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Current Research Studies

Allogeneic hematopoietic cell transplantation for patients with non-malignant disorders using Treosulfan, Fludarabine, and Thiotepa

FH9621

Condition: BMT
Phase: II
Clinicaltrials.gov ID: NCT03980769

What is the goal of the study?

To learn more about this study, please email the study team member listed below.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Lauri Burroughs
Study Team Member: Courtney Vandervlugt, cvanderv@fhcrc.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.